PET in Clinical Oncology

I. Basics: Physics, Chemistry, Camera techniques.- 1 Current status of PET in the United States.- 2 Physics, quality control.- 3 Image reconstruction, quantification and standard uptake value.- 4 Partial volume effects/corrections.- 5 Radiation safety in PET.- 6 FDG: biochemical concept and radiochemical synthesis.- 7 Current developments of 18F-labeled PET tracers in oncology.- 8 Cerium-doped lutetium oxyorthosilicate: a fast, efficient new scintillator.- 9 Optimization of gamma camera coincidence systems for PET in oncology.- 10 Combined PET/CT imaging using a single, dual-modality tomograph: a promising approach to clinical oncology of the future.- II Clinical application.- 11 Brain tumors.- 12 The role of FDG-PET in the management of oral squamous cell carcinoma (ICD-O-Da M-8070/3).- 13 PET in head and neck tumors.- 14 Carcinoma of unknown primary.- 15 Thyroid carcinomas.- 16 Lung cancer.- 17 Pancreatic cancer.- 18 Hepatobiliary tumors.- 19 Colorectal carcinomas.- 20 Hodgkin and Non-Hodgkin lymphoma.- 21 Testicular cancer.- 22 Prostate cancer.- 23 Malignant melanoma.- 24 Musculoskeletal tumors.- 25 Metastatic bone disease.- 26 Renal cell and urothelial cancer.- 27 Endocrine/neuroendocrine tumors.- 28 Breast cancer.- 29 Ovarian cancer.- 30 Pitfalls in the interpretation of PET studies.- 31 Monitoring of gene therapy with PET.- List of Radiopharmaceuticals.